NO20043371L - Kortikotropinfrigjorendefaktorreseptor-2 agonister - Google Patents

Kortikotropinfrigjorendefaktorreseptor-2 agonister

Info

Publication number
NO20043371L
NO20043371L NO20043371A NO20043371A NO20043371L NO 20043371 L NO20043371 L NO 20043371L NO 20043371 A NO20043371 A NO 20043371A NO 20043371 A NO20043371 A NO 20043371A NO 20043371 L NO20043371 L NO 20043371L
Authority
NO
Norway
Prior art keywords
corticotropin
releasing factor
agonists
factor receptor
receptors
Prior art date
Application number
NO20043371A
Other languages
English (en)
Norwegian (no)
Inventor
Robert Joseph Isfort
Adam Wieslaw Mazur
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of NO20043371L publication Critical patent/NO20043371L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57509—Corticotropin releasing factor [CRF] (Urotensin)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO20043371A 2002-01-16 2004-08-13 Kortikotropinfrigjorendefaktorreseptor-2 agonister NO20043371L (no)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US34911702P 2002-01-16 2002-01-16
US37633702P 2002-04-29 2002-04-29
US38889502P 2002-06-14 2002-06-14
US41198802P 2002-09-19 2002-09-19
PCT/US2003/001451 WO2003062268A2 (en) 2002-01-16 2003-01-16 Corticotropin releasing factor receptor 2 agonists

Publications (1)

Publication Number Publication Date
NO20043371L true NO20043371L (no) 2004-10-06

Family

ID=27617822

Family Applications (3)

Application Number Title Priority Date Filing Date
NO20043371A NO20043371L (no) 2002-01-16 2004-08-13 Kortikotropinfrigjorendefaktorreseptor-2 agonister
NO20043366A NO20043366L (no) 2002-01-16 2004-08-13 Kortikotropinfrigjorende faktor-2 reseptoragonister
NO20043396A NO20043396L (no) 2002-01-16 2004-08-16 Kortikotropinfrigjorende faktorreseptor 2-agonister

Family Applications After (2)

Application Number Title Priority Date Filing Date
NO20043366A NO20043366L (no) 2002-01-16 2004-08-13 Kortikotropinfrigjorende faktor-2 reseptoragonister
NO20043396A NO20043396L (no) 2002-01-16 2004-08-16 Kortikotropinfrigjorende faktorreseptor 2-agonister

Country Status (30)

Country Link
US (7) US6936585B2 (de)
EP (4) EP1465922B1 (de)
JP (3) JP4508649B2 (de)
KR (3) KR100758857B1 (de)
CN (3) CN100475844C (de)
AR (3) AR038142A1 (de)
AT (4) ATE334147T1 (de)
AU (2) AU2003205197B2 (de)
BR (3) BR0306826A (de)
CA (3) CA2470743C (de)
CY (1) CY1106133T1 (de)
DE (4) DE60321730D1 (de)
DK (2) DK1465921T3 (de)
ES (4) ES2299701T3 (de)
HK (1) HK1078095A1 (de)
IL (5) IL162530A0 (de)
MA (3) MA27591A1 (de)
MX (3) MXPA04006883A (de)
MY (1) MY140306A (de)
NO (3) NO20043371L (de)
NZ (3) NZ533598A (de)
PE (3) PE20030974A1 (de)
PL (3) PL371364A1 (de)
PT (2) PT1465923E (de)
RU (1) RU2294333C2 (de)
SA (3) SA03230564A (de)
SI (1) SI1465921T1 (de)
TW (3) TWI300442B (de)
WO (3) WO2003062269A2 (de)
ZA (1) ZA200404995B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040049009A1 (en) * 2000-09-22 2004-03-11 Klaus Eckart Methods for improving the antagonistic/agonistic properties of peptidic antagonists/agonists of the corticotropin-releasing factor receptor (crfr)
US6936585B2 (en) * 2002-01-16 2005-08-30 The Procter & Gamble Company Corticotropin releasing factor 2 receptor agonists
WO2005103690A2 (en) * 2004-04-24 2005-11-03 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with corticotropin releasing hormone receptor 2 (crhr2)
NZ562381A (en) * 2005-03-30 2011-06-30 Novartis Vaccines & Diagnostic Haemophilus influenzae type B
WO2007090087A2 (en) * 2006-01-27 2007-08-09 Research Development Foundation Use of corticotropin releasing factor receptor-2 inhibitors for treating insulin-related diseases
US20100197586A1 (en) * 2007-09-11 2010-08-05 Dorian Bevec Use of secretin and optionally urodilatin as therapeutic agents
WO2009039979A1 (en) * 2007-09-11 2009-04-02 Mondobiotech Laboratories Ag Use of the peptide pro-gly-thr-cys-glu-ile-cys-ala-tyr-ala-ala-cys-thr-gly-cys as a therapeutic agent
WO2009046874A1 (en) * 2007-09-11 2009-04-16 Mondobiotech Laboratories Ag Therapeutic combination of trh-potentiating peptide and stresscopin
EP2362881B1 (de) * 2008-11-04 2019-03-13 Janssen Pharmaceutica NV Crhr2-peptid-agonisten und anwendungen davon
EP2206726A1 (de) * 2009-01-08 2010-07-14 Universite Joseph Fourier Nichtinvasive Instrumente zum Nachweisen anfälliger atherosklerotischer Plaques
JP2013510167A (ja) * 2009-11-04 2013-03-21 ヤンセン ファーマシューティカ エヌ．ベー． ストレスコピン様ペプチドによる心不全の治療方法
US9314506B2 (en) 2011-10-24 2016-04-19 Research Development Foundation Methods for increasing insulin secretion by co-stimulation of corticotropin-releasing factor receptors
DK2814513T3 (en) * 2012-02-14 2018-02-26 Univ California Systemic administration and regulated expression of paracrine for cardiovascular disease and other conditions
JOP20170153A1 (ar) 2016-07-15 2019-01-30 Lilly Co Eli نظائر urocortin-2 جديدة معدلة بحمض دهني لعلاج داء السكري وأمراض الكلى المزمنة
MX2019004401A (es) 2016-10-20 2019-09-26 Cortene Inc Metodos de tratamiento y enfermedades resultantes de una respuesta de tension mal adaptada.
CN110755434B (zh) * 2018-07-27 2022-03-15 中国医学科学院药物研究所 化合物palosuran防治骨骼肌萎缩等疾病的用途

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5235036A (en) 1991-05-31 1993-08-10 The Salk Institute For Biological Studies Crf analogs
US5786203A (en) 1994-06-14 1998-07-28 Neurocrine Biosciences, Inc. Isolated nucleic acid encoding corticotropin-releasing factor2 receptors
EP0860501A3 (de) 1994-06-14 1999-05-19 Neurocrine Biosciences, Inc. Corticotropin freisetzende Rezeptoren des Faktor 2
US5824771A (en) 1994-12-12 1998-10-20 The Salk Institute For Biological Studies Cyclic CRF agonists
US5663292A (en) * 1994-12-12 1997-09-02 The Salk Institute For Biological Studies Cyclic CRF analogs
US5660824A (en) 1995-05-24 1997-08-26 Grabstein; Kenneth H. Muscle trophic factor
CA2223792A1 (en) 1995-06-13 1997-01-03 The Salk Institute For Biological Studies Urocortin peptides
US5869450A (en) 1996-03-06 1999-02-09 The Regents Of The University Of California Anti-inflammatory compositions and method with corticotropin-releasing factor analogs
ES2313978T3 (es) 2000-08-04 2009-03-16 Research Development Foundation Proteinas urocortina y sus usos.
US20020082409A1 (en) 2000-10-26 2002-06-27 Hsu Sheau Yu Stresscopins and their uses
US6670140B2 (en) * 2001-03-06 2003-12-30 The Procter & Gamble Company Methods for identifying compounds for regulating muscle mass or function using corticotropin releasing factor receptors
US6936585B2 (en) 2002-01-16 2005-08-30 The Procter & Gamble Company Corticotropin releasing factor 2 receptor agonists

Also Published As

Publication number Publication date
DK1465923T3 (da) 2007-07-02
US20030148957A1 (en) 2003-08-07
DE60321730D1 (de) 2008-07-31
ES2269976T3 (es) 2007-04-01
MA27592A1 (fr) 2005-11-01
EP1465923A1 (de) 2004-10-13
JP4508648B2 (ja) 2010-07-21
MXPA04006883A (es) 2004-12-06
US20030148956A1 (en) 2003-08-07
WO2003062268A3 (en) 2003-11-27
PE20030849A1 (es) 2003-12-01
JP4489434B2 (ja) 2010-06-23
TW200302276A (en) 2003-08-01
DE60307044T2 (de) 2007-02-15
MA27591A1 (fr) 2005-11-01
NZ533599A (en) 2007-03-30
CN1617887A (zh) 2005-05-18
US7192923B2 (en) 2007-03-20
PT1465921E (pt) 2006-12-29
PE20030974A1 (es) 2003-12-26
CA2470731C (en) 2011-06-21
JP4508649B2 (ja) 2010-07-21
CA2470743C (en) 2011-12-13
EP1465923B1 (de) 2007-05-16
BR0306826A (pt) 2005-09-06
EP1724283A3 (de) 2007-04-11
KR20040082390A (ko) 2004-09-24
ES2299701T3 (es) 2008-06-01
ZA200404995B (en) 2005-06-29
IL196384A0 (en) 2011-07-31
HK1078095A1 (en) 2006-03-03
MXPA04006885A (es) 2004-12-06
DE60307044D1 (de) 2006-09-07
PE20030747A1 (es) 2003-10-23
WO2003062277A1 (en) 2003-07-31
KR20040082392A (ko) 2004-09-24
RU2004124847A (ru) 2005-04-20
DK1465921T3 (da) 2006-11-27
WO2003062269A3 (en) 2003-11-06
CN1617886A (zh) 2005-05-18
EP1465921B1 (de) 2006-07-26
US7462597B2 (en) 2008-12-09
AU2003205197B2 (en) 2006-03-02
JP2005521387A (ja) 2005-07-21
IL162530A0 (en) 2005-11-20
NZ533598A (en) 2007-03-30
BR0306878A (pt) 2004-10-26
IL162431A0 (en) 2005-11-20
MA27590A1 (fr) 2005-11-01
DE60313845T2 (de) 2008-01-31
KR20040082389A (ko) 2004-09-24
BR0306838A (pt) 2005-04-05
ATE398632T1 (de) 2008-07-15
EP1724283B1 (de) 2008-06-18
NZ533600A (en) 2007-02-23
IL197774A0 (en) 2009-12-24
ATE383372T1 (de) 2008-01-15
CA2470743A1 (en) 2003-07-31
PT1465923E (pt) 2007-08-06
KR100758857B1 (ko) 2007-09-14
RU2294333C2 (ru) 2007-02-27
AR038144A1 (es) 2004-12-29
SI1465921T1 (sl) 2006-10-31
US20100197579A1 (en) 2010-08-05
TWI300442B (en) 2008-09-01
US20060025339A1 (en) 2006-02-02
AR038143A1 (es) 2004-12-29
CA2470656C (en) 2011-06-28
US7192924B2 (en) 2007-03-20
CN100475844C (zh) 2009-04-08
TW200302277A (en) 2003-08-01
US6936585B2 (en) 2005-08-30
DE60318547T2 (de) 2008-12-24
SA03230565B1 (ar) 2006-10-31
ES2287484T3 (es) 2007-12-16
IL162529A0 (en) 2005-11-20
US20080004435A1 (en) 2008-01-03
US20090124793A1 (en) 2009-05-14
CY1106133T1 (el) 2011-06-08
US7897731B2 (en) 2011-03-01
MXPA04006884A (es) 2004-12-06
AU2003237419B2 (en) 2006-04-13
WO2003062269A2 (en) 2003-07-31
DE60313845D1 (de) 2007-06-28
ES2309909T3 (es) 2008-12-16
CA2470656A1 (en) 2003-07-31
DE60318547D1 (de) 2008-02-21
EP1465921A2 (de) 2004-10-13
CN1617885A (zh) 2005-05-18
US7632933B2 (en) 2009-12-15
ATE334147T1 (de) 2006-08-15
KR100758858B1 (ko) 2007-09-14
PL373529A1 (en) 2005-09-05
US7608701B2 (en) 2009-10-27
WO2003062268A2 (en) 2003-07-31
JP2005525101A (ja) 2005-08-25
NO20043366L (no) 2004-10-06
MY140306A (en) 2009-12-31
ATE362488T1 (de) 2007-06-15
KR100735586B1 (ko) 2007-07-04
PL373139A1 (en) 2005-08-22
JP2005522191A (ja) 2005-07-28
NO20043396L (no) 2004-10-06
SA03230564B1 (ar) 2006-10-31
CA2470731A1 (en) 2003-07-31
AR038142A1 (es) 2004-12-29
TW200302278A (en) 2003-08-01
EP1465922B1 (de) 2008-01-09
CN100391972C (zh) 2008-06-04
US20030148958A1 (en) 2003-08-07
PL371364A1 (en) 2005-06-13
SA03230564A (ar) 2005-12-03
EP1724283A2 (de) 2006-11-22
SA03230565A (ar) 2005-12-03
EP1465922A2 (de) 2004-10-13

Similar Documents

Publication Publication Date Title
NO20043371L (no) Kortikotropinfrigjorendefaktorreseptor-2 agonister
DE602004006433D1 (de) Pyrrol-substituierte indole als inhibitoren von pai-1
WO2005005462A3 (en) Blys antagonists and uses thereof
BR0108713A (pt) Expressão hìbrida de proteìnas de neisseria
AU2002340010A1 (en) Substituted 3-pyridyl indoles and indazoles as c17,20 lyase inhibitors
EA200401169A1 (ru) Аминометилзамещенные тетрациклиновые соединения
ATE387435T1 (de) Substituirte benzosulfonamide als potenzierungsmittel von glutamatrezeptoren
WO2004022714A3 (en) Organic species that facilitate charge transfer to or from nanostructures
RS20050810A (en) 5,7-diaminopyrazolo(4,3-d)pyrimidines useful in the treatment of hypertension
ATE533365T1 (de) Herabsetzung von tabakbestandteilen
MXPA03006093A (es) Derivados de n(fenilsulfonil)glicina y su uso terapeutico.
NO20052524L (no) Aminerte isofiavonoidderivater og anvendelse derav
ATE406361T1 (de) 3-substituierte 5,6-diaryl-pyrazin-2- carbonsäureamid- und -2-sulfonsäureamidderivative als cb1 modulatoren
NO20042926L (no) Indolinonderivater nyttige sorn proteinkinaseinhibitorer
CY1107196T1 (el) Υποκατεστημενα παραγωγα 2,4-διϋδρο-πυρρολο (3,4-β) -κινολιν-9-ονης χρησιμα ως αναστολεις της φωσφοδιεστερασης
NO20071378L (no) Tiazolo-naftylsyrer.
WO2003104425A3 (en) NEW STABLE ANTI-CD22 ANTIBODIES
GB0327380D0 (en) Method
NO20045025L (no) Nye forbindelser
HRP20051005A2 (en) Process for the preparation of nonpeptide substituted spirobenzoazepine derivatives
CY1111432T1 (el) Τετραϋδροκινολινες για χρηση ως διαμορφωτες της μιτοτικης κινητικης πρωτεϊνης eg5
CY1105345T1 (el) Φαινυλαλκινια
MX2007004893A (es) Metodos y composiciones para el tratamiento de leucemia linfocitica cronica.
DE50309381D1 (de) Neue pyrimidin-4,6-dicarbons urediamide zur selektiven inhibierung von kollagenasen
NO20050432L (no) Fremgangsmate for overtrekking av en flate pa en skinnekomponent, og en skinnekomponent.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application